A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma-Reference-Cited by-同舟云学术

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma

Published:2022-08-19 Issue:12 Volume:28 Page:2090-2103
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Fan Wenhua¹²³,Wang Di¹,Li Guanzhang¹²³,Xu Jianbao⁴,Ren Changyuan⁵,Sun Zhiyan¹²³,Wang Zhiliang¹³^ORCID,Ma Wenping¹²³^ORCID,Zhao Zheng²³,Bao Zhaoshi¹²³,Jiang Tao¹²³^ORCID,Zhang Ying¹²³^ORCID

Affiliation:

1. Department of Neurosurgery, Beijing Tiantan Hospital Capital Medical University Beijing China

2. Department Molecular Neuropathology, Beijing Neurosurgical Institute Capital Medical University Beijing China

3. Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA) Beijing China

4. The Second Affiliated Hospital of Harbin Medical University Harbin China

5. Sanbo Brain Hospital Capital Medical University Beijing China

Funder

Beijing Postdoctoral Science Foundation

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Beijing Natural Science Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cns.13944

Reference49 articles.

1. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Clinical practice guidelines for the management of adult diffuse gliomas

4. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor

5. A Hybrid Nanovector of Suicide Gene Engineered Lentivirus Coated with Bioreducible Polyaminoglycosides for Enhancing Therapeutic Efficacy against Glioma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of stemness-related signature to optimize prognosis prediction and identify XMD8-85 as a novel therapeutic compound for glioma;Cellular Signalling;2024-08

2. Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy;BMC Immunology;2024-07-27

3. The war between the immune system and the tumor - using immune biomarkers as tracers;Biomarker Research;2024-05-30

4. Deciphering glycosylation-driven prognostic insights and therapeutic prospects in glioblastoma through a comprehensive regulatory model;Frontiers in Oncology;2024-05-22

5. Hypoxia‐related THBD⁺ macrophages as a prognostic factor in glioma: Construction of a powerful risk model;Journal of Cellular and Molecular Medicine;2024-05